Calidi Biotherapeutics Inc (CLDI)
2.17
-1.21
(-35.80%)
USD |
NYAM |
Nov 14, 12:28
Calidi Biotherapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 14, 2024 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Lumos Pharma Inc | 3.416 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.9236 |
| Theriva Biologics Inc | 0.0543 |
Price to Book Value Related Metrics
| Price | 2.17 |
| Earnings Yield | -908.6% |
| Market Cap | 17.54M |